CASP3 and Miyoshi myopathy: In regard to caspase-3, bortezomib or triple-drug treatment converted all the full-length (inactive) caspase-3 to cleaved caspase-3 (Figure 1C) in non-co-cultured RPMI 8226 MM cells.